...
首页> 外文期刊>Japanese Journal of Pharmacology >ANALYSIS AND DIFFERENTIATION OF THE MECHANISM IN DEVELOPMENT OF DRUG TOLERANCE
【24h】

ANALYSIS AND DIFFERENTIATION OF THE MECHANISM IN DEVELOPMENT OF DRUG TOLERANCE

机译:药物耐受性发展机理的分析与区分

获取原文

摘要

References(19) Cited-By(7) Repeated administration of many drugs, especially central acting drugs, cause a development of tolerance to same or related drugs. The development of drug tolerance is an important problem for the evalution of drug actions and for the determination of a schedule of drug administration. However, the mechanism of development of drug tolerance is still in obscure. On the other hand, it is recently well demonstrated by several investigators that single or repeated administration of various drugs induces an increase in the activities of drug-metabolizing enzymes of liver microsomes (1-4). Thus, the actions of the same drugs or other drugs given successively are markedly decreased through the increased rates of drug metabolisms (2, 4, 5). It has been well known that most of the central acting drugs are the inducers of drug-metabolizing enzymes of liver microsomes (2, 4, 5). The purpose of present communication, therefore, is to analyse and differentiate the mechanism of the development of drug tolerance. The results of the present investigation showed that there are two kind of drug tolerances and the first one would be called as apparent tolerance and the second one would be called as real tolerance. The development of the first one is mainely due to the induction of drug-metabolizing enzymes of liver microsomes and the second one is mainely due to the decreased tissue sensitivity to the drug. A simple and effective method to differentiate the two kinds of drug tolerance is the joint injection of inhibitors of enzyme protein synthesis, such as ethionine, with the designed drugs.
机译:参考文献(19)被引用的依据(7)许多药物,尤其是中枢作用药物的重复给药会导致对相同或相关药物的耐受性增强。药物耐受性的发展是评估药物作用和确定药物给药时间表的重要问题。然而,药物耐受性发展的机制仍不清楚。另一方面,最近有几位研究者充分证明,一次或多次服用各种药物会引起肝微粒体药物代谢酶活性的增加(1-4)。因此,通过增加药物代谢的速率,相继给予的相同药物或其他药物的作用会明显降低(2、4、5)。众所周知,大多数中枢作用药物是肝微粒体药物代谢酶的诱导剂(2、4、5)。因此,本次交流的目的是分析和区分药物耐受性发展的机制。本研究的结果表明,存在两种药物耐受性,第一种称为表观耐受性,第二种称为实际耐受性。第一个的发展主要是由于诱导肝微粒体的药物代谢酶,而第二个的发展主要是由于组织对药物的敏感性降低。区分两种药物耐受性的一种简单有效的方法是与设计的药物联合注射酶蛋白合成抑制剂(例如乙硫氨酸)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号